Ftse Mib
33.765,46
0,06%
DAX
17.920,07
-0,01%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.682,46
-0,95%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ImmuCell Corporation (ICCC) ImmuCell Corporation (ICCC) Notizie

ImmuCell Corporation

ICCC
5,00
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:16:44
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/4/202422:05GLOBEImmuCell Announces Preliminary, Unaudited Sales Results for..
06/3/202419:55EDGAR2Form 8-K - Current report
27/2/202422:05EDGAR2Form 8-K - Current report
27/2/202422:05GLOBEImmuCell Announces Unaudited Financial Results for the..
16/2/202415:30GLOBEImmuCell to Announce Unaudited Financial Results for the..
08/1/202422:05EDGAR2Form 8-K - Current report
08/1/202422:05GLOBEImmuCell Announces Preliminary, Unaudited Sales Results for..
16/11/202321:22EDGAR2Form 8-K - Current report
13/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:05EDGAR2Form 8-K - Current report
13/11/202322:05GLOBEImmuCell Announces Unaudited Financial Results for the..
07/11/202318:15GLOBEImmuCell to Announce Unaudited Financial Results for the..
05/10/202322:05EDGAR2Form 8-K - Current report
05/10/202322:05GLOBEImmuCell Announces Preliminary, Unaudited Sales Results for..
06/9/202318:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202320:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202314:00GLOBEImmuCell Announces Submission of CMC Technical Section to..
10/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:05EDGAR2Form 8-K - Current report
10/8/202322:05GLOBEImmuCell Announces Unaudited Financial Results for the..
07/8/202318:00GLOBEImmuCell to Announce Unaudited Financial Results for the..
21/7/202315:04EDGAR2Form 8-K - Current report
13/7/202320:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/7/202322:05EDGAR2Form 8-K - Current report
11/7/202322:05GLOBEImmuCell Announces Preliminary, Unaudited Sales Results for..
29/6/202319:02EDGAR2Form 8-K - Current report
28/6/202322:05GLOBEImmuCell Announces Change in Timing of Anticipated FDA..
21/6/202322:05GLOBEImmuCell Appoints Bryan K. Gathagan to Board of Directors
15/6/202322:05GLOBEImmuCell Announces Approval of Principal Terms of a $3..
16/5/202315:00GLOBEImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
11/5/202322:05GLOBEImmuCell Announces Unaudited Financial Results for the..
04/5/202312:30GLOBEImmuCell to Announce Unaudited Financial Results for the..
Apertura: Min: Max:
Chiusura: 5,00

La tua Cronologia

NASDAQ
ICCC
ImmuCell
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network